Divisait develops a niche portfolio of healthcare and enterprise software products including DV2EEMVC, Proxia PHR, Proxia Suite, and SparkSpace, where vulnerabilities have centered on deserialization of untrusted data. Treat this as a focused vendor profile rather than a broad trend line; live severity, exploitation, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Divisait over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2019-18956CRITICAL Divisa Proxia Suite 9 < 9.12.16, 9.11.19, 9.10.26, 9.9.8, 9.8.43 and 9.7.10, 10.0 < 10.0.32, and 10.1 < 10.1.5, SparkSpace 1.0 < 1.0.30, 1.1 < 1.1.2, and 1.2 < 1.2.4, and Proxia PH | Dec 17, 2019 | 9.8 | 31 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Divisait.
Media articles that mention a CVE ID that affects a product developed by Divisait — matched by CVE ID, not by vendor name.